» Articles » PMID: 24843303

Fundus Autofluorescence Imaging: Fundamentals and Clinical Relevance

Overview
Specialty Ophthalmology
Date 2014 May 21
PMID 24843303
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Fundus autofluorescence (FAF), a relatively new imaging modality, focuses on the fluorescent properties of pigments in the retina to generate images that help us view various disease processes from a different perspective. It aids us in the understanding of the pathophysiology of different retinal disorders. Recently, FAF imaging is being used commonly to help us in the diagnosis, prognosis as well as in determining the treatment response of various retinal disorders. It generates an image based on the distribution pattern of a fluorescent pigment called lipofuscin. Knowing the distribution pattern of lipofuscin in the normal retina is key to understanding an FAF image representing a retinal pathology. Like most other imaging modalities, FAF comes with its own limitations, taking steps to overcome these limitations will be of utmost importance in using this imaging modality to its fullest potential.

Citing Articles

In Vivo Imaging of Rodent Retina in Retinal Disease.

Beryozkin A, Byrne L Methods Mol Biol. 2024; 2848:151-167.

PMID: 39240522 DOI: 10.1007/978-1-0716-4087-6_10.


Fundus Autofluorescence in Diabetic Retinopathy.

Dumitrescu O, Zemba M, Branisteanu D, Pirvulescu R, Radu M, Stanca H J Pers Med. 2024; 14(8).

PMID: 39201985 PMC: 11355256. DOI: 10.3390/jpm14080793.


Longitudinal assessment of female carriers of choroideremia using multimodal retinal imaging.

Gocuk S, Ayton L, Edwards T, McGuinness M, MacLaren R, Taylor L Br J Ophthalmol. 2024; 109(2):293-299.

PMID: 39122355 PMC: 11866302. DOI: 10.1136/bjo-2024-325578.


Label-Free Optical Technologies for Middle-Ear Diseases.

Zhou Z, Pandey R, Valdez T Bioengineering (Basel). 2024; 11(2).

PMID: 38391590 PMC: 10885954. DOI: 10.3390/bioengineering11020104.


Clinical and Autofluorescence Findings in Eyes with Pinguecula and Pterygium.

Beheshtnejad A, Ghassemi H, Abdolkhalegh H, Atighehchian M J Ophthalmic Vis Res. 2023; 18(3):260-266.

PMID: 37600917 PMC: 10432937. DOI: 10.18502/jovr.v18i3.13773.


References
1.
Yeh S, Forooghian F, Wong W, Faia L, Cukras C, Lew J . Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol. 2010; 128(1):46-56. PMC: 3025103. DOI: 10.1001/archophthalmol.2009.368. View

2.
Schmitz-Valckenberg S, Holz F, Bird A, Spaide R . Fundus autofluorescence imaging: review and perspectives. Retina. 2008; 28(3):385-409. DOI: 10.1097/IAE.0b013e318164a907. View

3.
Lois N, Owens S, Coco R, Hopkins J, Fitzke F, Bird A . Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol. 2002; 133(3):341-9. DOI: 10.1016/s0002-9394(01)01404-0. View

4.
Penha F, Navajas E, Aggio F, Rodrigues E, Farah M . Fundus autofluorescence in multiple evanescent white dot syndrome. Case Rep Ophthalmol Med. 2012; 2011:807565. PMC: 3350043. DOI: 10.1155/2011/807565. View

5.
Abu-Yaghi N, Hartono S, Hodge D, Pulido J, Bakri S . White dot syndromes: a 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm. 2011; 19(6):426-30. PMC: 3346947. DOI: 10.3109/09273948.2011.624287. View